Influenza: Investigational intranasal vaccine deemed safe and elicits strong immune response: Phase 1 study
by Press Release from Outbreak News Today on (#5DPQ6)
An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal of Clinical Investigation. The investigational vaccine, called Ad4-H5-VTN, is a recombinant, replicating adenovirus vaccine designed to spur antibodies to hemagglutinin, a protein found on the surface of influenza viruses that attaches [...]
The post Influenza: Investigational intranasal vaccine deemed safe and elicits strong immune response: Phase 1 study appeared first on Outbreak News Today.